InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Jamil Khurram. Director active across 1 company, notably Galectin Therapeutics INC. Cumulatively, 3 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €2k. Activity tracked since 23 December 2024. The latest transaction was disclosed on 26 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations